Explore All 2732 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 16, 2013 |
| Target | Solta Medical |
| Sector | Medical Products |
| Buyer(s) | Bausch Health |
| Deal Type | Add-on Acquisition |
| Deal Value | 250M USD |
| Advisor(s) | Piper Sandler & Co. (Financial) Fenwick & West (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 9.6B USD (2024) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| Deal Context for Buyer | # |
|---|---|
| Overall | 25 of 36 |
| Sector: Medical Products | 3 of 6 |
| Type: Add-on Acquisition | 18 of 26 |
| State: California | 5 of 7 |
| Country: United States | 13 of 23 |
| Year: 2013 | 4 of 4 |
| Size (of disclosed) | 18 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-11-01 |
Valeant Pharmaceuticals Caladryl
India Valeant Pharmaceuticals Caladryl is an anti-pruritic solution known for dermatosis application for minor skin irritations and itching. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-03 |
PreCision Dermatology
Cumberland, Rhode Island, United States PreCision Dermatology, Inc. is a specialty pharmaceutical company developing, manufacturing and marketing prescription and consumer dermatology products. Our mission is to develop innovative skincare therapies with proven clinical performance that patients prefer and physicians are confident to prescribe. |
Buy | $475M |
